VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
EDVA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
EDVAEndovia Health Sciences, Inc.
$0.19$3M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksEDVABalance Sheet

Endovia Health Sciences, Inc. (EDVA) Balance Sheet

13Y historyFree accessUpdated daily

Financial leverage has reached critical levels, evidenced by a debt-to-equity ratio of 8.21 and a precarious current ratio of 0.04 as of 2026Q1.

Income StatementBalance SheetCash FlowRatios

EDVA Balance Sheet

Annual statement

EDVA Balance Sheet

Endovia Health Sciences, Inc. (EDVA) balance sheet — 13-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13
Total Current Assets900.41K631.99K1.9M3.98M10.66M8.34M2.24M382.21K349.67K194.39K293.14K196K119.41K71.86K
Cash & Short-Term Investments242.7K281.44K15.35K379.98K4.43M4.18M380K23.32K6.98K17.92K61.66K7.34K24.91K669
Cash Only242.7K281.44K15.35K379.98K4.43M4.18M380K23.32K6.98K17.92K61.66K7.34K24.91K669
Short-Term Investments00000000000000
Accounts Receivable86.47K108.97K631.63K1.12M2.16M1.16M575.78K309.62K300.99K151.26K206.25K167.06K80.18K58.65K
Days Sales Outstanding-162.69544.3555.4821.7743.5237.391.37111.0383.9261.6674.3767.9548.345.04
Inventory54.92K33.54K893.06K2.25M3.72M1.92M798.27K30.56K41.7K25.21K25.23K21.59K14.31K12.54K
Days Inventory Outstanding335.38217.9485.7961.9111.6280.38150.4621.9225.1420.8918.9918.4620.419.38
Other Current Assets416.01K0000473.46K316.57K18.72K000000
Total Non-Current Assets175.93K333.7K855.07K5.92M6.65M8.04M6.98M43.84K58.63K46.64K62.19K43.75K47.31K23.86K
Property, Plant & Equipment060.97K556.14K905.94K1.24M1.6M981.34K43.84K58.63K46.64K62.19K43.75K47.31K23.86K
Fixed Asset Turnover-4.46x1.20x7.47x20.81x14.59x7.07x2.34x23.21x22.33x19.20x16.28x20.51x12.81x19.92x
Goodwill000256.82K256.82K256.82K5.67M0000000
Intangible Assets0004.46M4.85M5.6M219.51K0000000
Long-Term Investments675.92K250K250K250K250K250K250K0000000
Other Non-Current Assets022.73K48.92K49.45K49.29K0-141.83K0000000
Total Assets1.08M965.69K2.76M9.9M17.3M16.39M9.23M426.06K408.3K241.03K355.33K239.75K166.71K95.72K
Asset Turnover-0.06x0.08x1.51x1.90x1.05x0.69x0.25x2.39x3.21x3.71x2.85x3.74x3.63x4.97x
Asset Growth %-60.6%-65%-72.13%-42.8%5.61%77.6%2065.4%4.35%69.4%-32.17%48.21%43.81%74.18%-
Total Current Liabilities16.83M16.26M19.37M14.75M4.97M6.48M5.42M643.1K405.46K299.88K290.36K220.06K158.58K137.58K
Accounts Payable4.09M4.81M5.23M4.44M3.38M1.91M1.52M353.85K331.03K226.21K209.07K135.21K71.28K43.04K
Days Payables Outstanding6.81K31.26K502.6122.14101.4879.96286.83253.81199.62187.47157.37115.58101.666.49
Short-Term Debt6.39M6.61M10.22M8.33M1.08M3.71M2.43M270.54K74.42K73.67K81.29K84.85K87.31K94.54K
Deferred Revenue (Current)00000561.95K811.65K-551.7K-331.03K-226.21K-209.07K0-71.28K0
Other Current Liabilities6.35M1.67M0091.8K-172.87K148.89K551.7K000000
Current Ratio0.05x0.04x0.10x0.27x2.15x1.29x0.41x0.59x0.86x0.65x1.01x0.89x0.75x0.52x
Quick Ratio0.05x0.04x0.05x0.12x1.40x0.99x0.27x0.55x0.76x0.56x0.92x0.79x0.66x0.43x
Cash Conversion Cycle-6.64K-30.5K-361.33-38.4653.6637.72-45.01-120.85-90.56-104.92-64.01-29.17-32.89-2.08
Total Non-Current Liabilities06.39K2.02M753.78K3.02M1.03M3.91M2.06K5.5K14.01K25.3K21.17K28.77K17.78K
Long-Term Debt03.42K1.97M457.66K2.54M300K1.91M2.06K5.5K14.01K25.3K21.17K28.77K17.78K
Capital Lease Obligations14.66K2.98K53.7K296.13K480.67K732.69K25.52K0000000
Deferred Tax Liabilities00000000000000
Other Non-Current Liabilities0000001.98M0000000
Total Liabilities16.83M16.27M21.39M15.5M7.98M7.51M9.33M645.17K410.95K313.89K315.67K241.23K187.35K155.36K
Total Debt6.39M6.67M12.55M9.35M4.37M5.04M4.42M291.32K79.92K87.68K106.6K106.02K116.08K112.32K
Net Debt6.14M6.39M12.54M8.97M-65.75K856.76K4.04M268K72.94K69.76K44.94K98.68K91.17K111.65K
Debt / Equity-0.41x---0.47x0.57x----2.69x---
Debt / EBITDA-0.48x-------0.62x-18.51x2.46x-44.40x
Net Debt / EBITDA-0.46x-------0.56x-7.80x2.29x-44.13x
Interest Coverage7.79x-4.57x-2.22x-2.69x-85.05x-65.27x-8.89x-533.73x12.94x-32.06x-9.46x4.57x-6.67x0.16x
Total Equity-15.75M-15.3M-18.63M-5.61M9.32M8.87M-102K-219.11K-2.66K-72.86K39.67K-1.49K-20.64K-59.65K
Equity Growth %-81.07%17.89%-232.45%-160.13%5.06%8798.99%53.45%-8140.2%96.35%-283.68%2771.31%92.8%65.4%-
Book Value per Share-5.14-28.10-55.69-21.1339.8949.12-2.64-8.90-0.11-3.101.69-0.00-0.01-0.02
Total Shareholders' Equity-15.75M-15.3M-18.63M-5.61M9.32M8.87M-102K-219.11K-2.66K-72.86K39.67K-1.49K-20.64K-59.65K
Common Stock4.13K3K1.67K44.33K41.09K33.6K21.16K345.51K245.51K243.51K208.51K118.52K118.52K49.41K
Retained Earnings-186.83M-181.9M-155.83M-133.33M-112.33M-90.64M-61.59M-725.41K-248.17K-316.38K-168.85K-120K-139.15K-109.06K
Treasury Stock0000000-50K0-150K0000
Accumulated OCI12.72K33.83K81.18K-16.58K-20.47K000-92.91K-93.16K-76.2K0-24.46K0
Minority Interest00000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Imminent Going Concern Risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Rapid Erosion of Asset Base

As reported in recent financial filings, SBEV's total assets have plummeted from $22.5 million in 2025Q3 to just $770,000 by 2026Q1, signaling a severe contraction in the company's resource base and a potential liquidation of core operational assets to sustain ongoing corporate survival.

The precipitous decline in total assets suggests that the company is rapidly consuming its remaining value to offset persistent operating losses. This trajectory indicates that the business model is no longer capable of maintaining the asset scale required for competitive beverage distribution.

Critical Shortage of Working Capital

Based on the most recent quarterly data, SBEV's current ratio has deteriorated to a precarious 0.04, reflecting an extreme inability to cover short-term obligations with existing liquid assets as cash reserves dwindle to a nominal $381,200 against significant outstanding liabilities.

A current ratio of 0.04 is indicative of a severe liquidity crisis that leaves the company with virtually no buffer against operational shocks or supply chain disruptions. Investors should monitor this metric closely, as it suggests the company is likely reliant on emergency financing to meet basic payroll and vendor obligations.

Unsustainable Leverage Amidst Revenue Collapse

According to the provided balance sheet figures, SBEV's debt-to-equity ratio has spiked to 8.21 as of 2026Q1, highlighting a reliance on debt financing that is increasingly disconnected from the company's ability to generate revenue or maintain a positive equity position.

The high leverage ratio in the context of near-zero revenue suggests that the company's debt burden is likely becoming unserviceable. This capital structure appears to be a necessity-driven attempt to delay insolvency rather than a strategic use of leverage to fuel growth.

Persistent Erosion of Shareholder Equity

As evidenced by the historical balance sheet data, SBEV's retained earnings have deepened to a deficit of $184.4 million, reflecting a long-term pattern of value destruction that has consistently eroded the company's equity base and left it in a state of extreme financial distress.

The consistent accumulation of negative retained earnings indicates that the company has failed to achieve a profitable scale despite its brand acquisition strategy. This persistent deficit suggests that future capital raises may be highly dilutive to existing shareholders as the company attempts to recapitalize its balance sheet.

Hidden Risks in Asset Valuation

Based on the reported financial statements, the total disappearance of $20 million in goodwill between 2025Q3 and 2026Q1 suggests that previous acquisition-related assets have been fully impaired, which may indicate that the company's historical brand investments have failed to provide any lasting economic value.

The sudden write-down of goodwill warrants further investigation, as it confirms that the company's past strategy of acquiring beverage brands has not translated into tangible assets. This impairment highlights the risk that the company's remaining book value may still be overstated relative to its actual liquidation potential.

EDVA — Frequently Asked Questions

Quick answers to the most common questions about buying EDVA stock.

What are the total assets of Endovia Health Sciences, Inc. (EDVA)?

As of 2025, Endovia Health Sciences, Inc. (EDVA) had total assets of $1.0M including $0.6M in current assets.

How much debt does Endovia Health Sciences, Inc. (EDVA) have?

Endovia Health Sciences, Inc. (EDVA) carries total debt of $6.7M, offset by $0.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Endovia Health Sciences, Inc.?

Endovia Health Sciences, Inc. (EDVA) has total shareholders' equity (book value) of $-15.3M ($-28.10 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Endovia Health Sciences, Inc.'s current ratio and liquidity?

Endovia Health Sciences, Inc. (EDVA) reported a current ratio of 0.04x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.